Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Study Results
Related Studies
Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS)
This study has been completed.
Study NCT01382901 Information provided by Luitpold Pharmaceuticals
First Received on February 23, 2011. Last Updated on July 8, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Restless Legs Syndrome (RLS)
Additional conditions recognized in this trial
Psychomotor Agitation
Restless Legs Syndrome
More general conditions related to this trial
Dyskinesias
Dyssomnias
Mental Disorders
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Parasomnias
Psychomotor Disorders
Signs and Symptoms
Sleep Disorders
Sleep Disorders, Intrinsic
Interventions listed in this trial
Ferric Carboxymaltose (FCM)
Placebo
Additional drug interventions recognized in this trial
Ferric Compounds
Iron
More general drug interventions related to this trial
Growth Substances
Hematinics
Hematologic Agents
Micronutrients
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Trace Elements
Sponsors listed in this trial
Luitpold Pharmaceuticals
Back to top of Main Content
